Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lines

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
AIDS Research and Human Retroviruses|November 16, 2001
Specific proliferative T cell responses and antibodies elicited by vaccination with simian immunodeficiency virus Nef do not confer protection against virus challengeA M Wade-Evans, J Stott, T Hanke, et al.
The Journal of General Virology|March 31, 1998
Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virusE J Stott, N Almond, K Kent, et al.
Journal of Medical Primatology|May 12, 2007
Immunological responses and viral modulatory effects of vaccination with recombinant modified vaccinia virus Ankara (rMVA) expressing structural and regulatory transgenes of simian immunodeficiency virus (SIVmac32H/J5M)N Berry, R Stebbings, S Brown, et al.
Journal of Medical Primatology|May 23, 2007
Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivoD Ferguson, A Wade-Evans, W Elsley, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
AIDS Research and Human Retroviruses|November 16, 2001
Specific proliferative T cell responses and antibodies elicited by vaccination with simian immunodeficiency virus Nef do not confer protection against virus challengeA M Wade-Evans, J Stott, T Hanke, et al.
The Journal of General Virology|March 31, 1998
Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virusE J Stott, N Almond, K Kent, et al.
Journal of Medical Primatology|May 12, 2007
Immunological responses and viral modulatory effects of vaccination with recombinant modified vaccinia virus Ankara (rMVA) expressing structural and regulatory transgenes of simian immunodeficiency virus (SIVmac32H/J5M)N Berry, R Stebbings, S Brown, et al.
Journal of Medical Primatology|May 23, 2007
Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivoD Ferguson, A Wade-Evans, W Elsley, et al.
Pageof 6